ACE2 and COVID-19: Analyses of bronchoalveolar lavage fluid from COVID-19 patients and controls identified alterations in bacterial communities capable of modifying heparan sulfate, which is required for SARS-CoV-2 binding to angiotensin converting enzyme 2 (ACE2) (8).